| 000 | 01432 a2200397 4500 | ||
|---|---|---|---|
| 005 | 20250513201252.0 | ||
| 264 | 0 | _c20000229 | |
| 008 | 200002s 0 0 eng d | ||
| 022 | _a1420-8008 | ||
| 024 | 7 |
_a10.1159/000017208 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aImbimbo, B P | |
| 245 | 0 | 0 |
_aA 6-month, double-blind, placebo-controlled trial of eptastigmine in Alzheimer's disease. _h[electronic resource] |
| 260 |
_bDementia and geriatric cognitive disorders _c |
||
| 300 |
_a17-24 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 |
_aAlzheimer Disease _xdiagnosis |
| 650 | 0 | 4 |
_aCholinesterase Inhibitors _xadministration & dosage |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 | _aDouble-Blind Method |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aFollow-Up Studies |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aNeuropsychological Tests |
| 650 | 0 | 4 |
_aPhysostigmine _xadministration & dosage |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aTroetel, W M | |
| 700 | 1 | _aMartelli, P | |
| 700 | 1 | _aLucchelli, F | |
| 773 | 0 |
_tDementia and geriatric cognitive disorders _gvol. 11 _gno. 1 _gp. 17-24 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1159/000017208 _zAvailable from publisher's website |
| 999 |
_c10584827 _d10584827 |
||